Foley Hoag Advises PatientsLikeMe in Investment by and Partnering Agreements with iCarbonX

May 04, 2017

Foley Hoag LLP recently advised personalized health network PatientsLikeMe in its investment and partnering agreements with digital life company iCarbonX, pursuant to which iCarbonX has made a substantial investment in PatientsLikeMe and agreed to provide certain multi-omics characterization services to the company.

Based in Cambridge, Mass., PatientsLikeMe provides a digital platform to collect and aggregate patient-generated health data, giving patients the real-world context to make more informed decisions and improve their outcomes. Today more than 500,000 people use to track and share information about 2,700 conditions. Numerous pharmaceutical companies and government organizations have collaborated with PatientsLikeMe and gathered insights from its data to better treat, and understand what it is like to live with, disease.

The agreements with iCarbonX make PatientsLikeMe a cornerstone in iCarbonX’s Digital Life Alliance, an expanding ecosystem of leading health technology and application companies that are collaborating to digitize and analyze all aspects of life. The alliance’s ultimate aim is to merge comprehensive biological and patient-generated data with artificial intelligence (AI) technology to help people better understand the medical, behavioral and environmental factors in their lives that may accelerate or mitigate disease, and optimize health.

Foley Hoag attorneys Greg Ploussios, Jonathan Romiti, Nick Romanos, Terry Martland, Stacie Aarestad, Adam Wade, Diana Snyder and Mark Potash, among others, advised PatientsLikeMe in the transaction.